AMD 2022 Jul: AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD Progression

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/12/27/d0/1227d0ad-be48-c3a7-a6d5-59e7b0337a98/mza_13134445355517464192.jpg/600x600bb.jpg

Eye Research Deep Dive: Doctopus the Octometrist

Dr Michael Nelson, OD FAAO

88 episodes

2 days ago

This podcast provides an easy to listen summary of eye care topics from eye research studies. New Shows Tuesdays and Thursdays. Listen to your AI experts Doctopus the Octometrist and Doc Otter Noh dive deep into the latest eye care research studies. This is an A.I. assisted podcast created and curated by Dr. Michael Nelson, OD FAAO. Our goal is to keep you up to date with the latest research on eye care topics. DISCLAIMER: We highly recommend you read each article yourself for accuracy.

Medicine

Health & Fitness

RSS

All content for Eye Research Deep Dive: Doctopus the Octometrist is the property of Dr Michael Nelson, OD FAAO and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43059748/43059748-1739638439093-5d16cbd28dbe5.jpg

AMD 2022 Jul: AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD Progression

Eye Research Deep Dive: Doctopus the Octometrist

9 minutes 27 seconds

2 days ago

AMD 2022 Jul: AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD Progression

AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD Progression

Chew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W; AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 1;140(7):692-698. doi: 10.1001/jamaophthalmol.2022.1640. PMID: 35653117; PMCID: PMC9164119.

https://pmc.ncbi.nlm.nih.gov/articles/pmid/35653117/